LITS

Lite Strategy, Inc. is a clinical-stage pharmaceutical company based in San Diego, California, dedicated to advancing innovative therapies for cancer treatment. With a robust pipeline of proprietary compounds, the company aims to address unmet medical needs in oncology through targeted therapies and novel approaches. Leveraging advanced research methodologies, Lite Strategy is committed to improving the outcomes for patients battling cancer, positioning itself as a significant player in the evolving biopharmaceutical landscape.